The final mini-symposium at #IUCLS2024 on small molecule inhibitors concludes with a panel discussion discussing ongoing trials of this class of agents, with moderator Dr Vaishalee Kenkre and speakers Adam Kittai Kami Maddocks and Dr Changchun Deng

Keynote Presentation time! Co-chairs Soni Smith MD Andrew M. Evens, DO, MBA, MSc Neha Mehta-Shah and Tim Fenske award Andrew Zelenetz MD, PhD from Memorial Sloan Kettering Cancer Center with the Keynote Award before his talk on overcoming barriers to improve outcomes in lymphoma #IUCLS2024

We add some international flair to #IUCLS2024 as Stefano Luminari, MD from Italy discusses his approaches to treating older/elderly patients with newly diagnosed #DLBCL .

🎶🎸Rutgers Cancer Institute RWJBarnabas Dr Joanna M. Rhodes, MD, MSCE trying to psych out Mass General Cancer Center Dr Jacob Soumerai with her walk-up song on their debate on “Measuring MRD is the Standard of Care in CLL” at #IUCLS2024

Will CLL follow a similar path as multiple myeloma w/ MRD?

BioAscend

For the “duel” symposium at #IUCLS2024 Joanna M. Rhodes, MD, MSCE and Dr Jacob Soumerai from Mass General Cancer Center debate the role of MRD in #CLL . Do you think MRD is the standard of care in CLL?

The mini-symposium on Hodgkin lymphoma at #IUCLS2024 concludes with an esteemed panel of HL experts including moderator Andrew M. Evens, DO, MBA, MSc and speakers Justine Kahn MD, MS Chelsea C Pinnix MD PhD Dr Boyu Hu from Huntsman Cancer Institute and Dr Sarah Rutherford from WCM Lymphoma.

Day 2 of #IUCLS2024 opens with the DEI Keynote by Christopher Flowers from MD Anderson Cancer Center providing updates on strategies to reduce barriers that limit access to lymphoma care.

Was loads of fun talking with Bloodbytes, Anamarija Perry and Payal Sojitra at the #IUCLS24 #lymsm A big shoutout to Michigan Pathology University of Chicago Hematology/Oncology Cc: Lauren Smith, MD, HEC-C BioAscend Soni Smith MD Andrew M. Evens, DO, MBA, MSc Neha Mehta-Shah Kamran Mirza MD PhD - کامران مرزا

With Reem Karmali Тyler 21st International Ultmann Chicago Lymphoma Symposium. Had a great time! BioAscend

Day 1 of #IUCLS2024 concludes with a mini-symposium and panel focused on the management of bispecific antibodies with panelists Jennifer Crombie, MD David Russler-Germain, MD/PhD and L. Elizabeth Budde, M.D., Ph.D. with moderator Dr Reem Karmali of Northwestern Medicine.

Get out your microscopes! 📷 It’s time for the Hematopathology Tumor Board at #IUCLS2024 Andrew M. Evens, DO, MBA, MSc Girish Venkataraman and others discuss some of the challenges of diagnosing MYC/EBV+ lymphomas.

🤔🤔🤔

What is UChicagoCancerCenter Dr Soni Smith MD first walk up song at the #IUCLS2024 ?

See/HEAR below! 🎶🎸🎹🎼

Vaniam Group LLC

Co-chair Soni Smith MD opens the afternoon General Session with a mini-symposium on T-cell lymphoma, including talks on epigenetics by Enrica Marchi CTCL by Neha Mehta-Shah and regulatory implications by Dr Swaminathan Iyer from MD Anderson Cancer Center #IUCLS2024

First conference of Heme/Onc Fellowship! Excited for all the learning and expert talks #IUCLS2024

Co-chair Neha Mehta-Shah introduces the second mini-symposium of the day focused on advanced technology in cancer care, including AI and CRISPR technologies #IUCLS2024

1️⃣st walk up song “A sky full of stars” by Coldplay.

As stated, the #lymphoma sky is full of stars 🌟🌟🌟 including senior & rising/new faculty, researchers, nurses, pharmacists, etc. We look forward to showcase these many stars at the #IUCLS2024 today & tomorrow.

BioAscend

Poll: In our mini-symposium on bispecific antibodies at #IUCLS2024 , we discuss the practical aspects of their use and management. Which of the following treatment-related factors of bispecifics are most problematic for you?

We kick off #IUCLS2024 with Andrew M. Evens, DO, MBA, MSc welcoming participants to the 21st International Ultmann Chicago Lymphoma Symposium, and he quotes Coldplay that this meeting, like the sky, is full of stars.

#IUCLS2024 is taking place this weekend! Andrew M. Evens, DO, MBA, MSc will be moderating the #HodgkinLymphoma session on April 20, which will feature an interactive panel and Q&A session.

There's still time to register: loom.ly/AttnTGU